IQVIA MARKET PROGNOSIS
Market Prognosis is a strategic market forecasting publication that provides unparalleled insights into the key issues affecting the local pharmaceutical and healthcare industries.
The Market Prognosis country-level forecasts for 2023-2027 are now available.
In our latest reports, discover:
- How the campaign against corruption in the healthcare sector, launched in July 2023, is expected to impact pharmaceutical market growth in China
- How a change in the ‘PASKWIL’ criteria, used by a specialist oncology committee to issue reimbursement recommendations, might impact the future of cancer care in the Netherlands
- The implications of the Czech government’s measures to address drug supply shortages, low generic prices, and declining profitability for the Czech pharmaceutical market
- The impact of South Africa’s energy crisis on the country’s healthcare ecosystem over the next five years
- How the new health law and upcoming 2024 elections promise to bring key healthcare reforms to boost Indonesia’s pharmaceutical market
- How a ruling by Chile’s Supreme Court risks seriously damaging the country’s private healthcare system and preventing advances in key healthcare initiatives
IQVIA Market Prognosis’ regional overview summaries are also available in MS Power BI format* providing enhanced interactive visualization of Market Prognosis pharmaceutical forecasts and analytics across markets in North America, Europe, LATAM, Asia-Australia and MEA regions, in addition to Pharmerging and Core Countries.
*To be published on 13th October, 2023.
Market Prognosis forecasting expertise can help you to understand the key drivers and constraints of the pharmaceutical markets for better strategic planning and decision making.
Register your details below to learn more.
Copyright © 2024 IQVIA Holdings Inc. and its affiliates. All rights reserved. Privacy Statement
